4D Molecular Therapeutics, Inc.
FDMT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650648
In the last 90 days, 4D Molecular Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $771.2M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding 4D Molecular Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 100 | 110 | +10 |
| Shares | 41.2M | 41.9M | +664.9K (+1.6%) |
| Value | $745.3M | $533.6M | −$211.8M (−28.4%) |
New holders (20)
Institutions that held 4D Molecular Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| GMT Capital Corp | 151,200 | $1.92M | 0.07% |
| Panagora Asset Management Inc | 75,688 | $963.5K | 0.01% |
| Trexquant Investment LP | 44,443 | $565.8K | 0.01% |
| Privium Fund Management B.V. | 33,680 | $428.7K | 0.13% |
| HighVista Strategies LLC | 33,419 | $425.4K | 0.20% |
| ExodusPoint Capital Management, LP | 29,307 | $373.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 26,330 | $335.0K | 0.03% |
| HRT Financial LP | 26,017 | $331.0K | 0.00% |
| Peloton Wealth Strategists | 25,000 | $318.0K | 0.15% |
| Aigen Investment Management, LP | 16,985 | $216.2K | 0.04% |
| SG Americas Securities, LLC | 12,254 | $156.0K | 0.00% |
| Fox Run Management, L.L.C. | 12,162 | $154.8K | 0.05% |
| Affinity Wealth Management LLC | 11,471 | $146.0K | 0.03% |
| Point72 Middle East FZE | 11,304 | $143.9K | 0.01% |
| State Board of Administration of Florida Retirement System | 11,187 | $142.4K | 0.00% |
| Principal Financial Group Inc | 11,041 | $140.6K | 0.00% |
| Vident Advisory, LLC | 10,574 | $134.6K | 0.00% |
| Allspring Global Investments Holdings, LLC | 523 | $6.66K | 0.00% |
| Simplex Trading, LLC | 266 | $3.00K | 0.00% |
| Harbour Investments, Inc. | 25 | $318 | 0.00% |
Sold out (10)
Institutions that held 4D Molecular Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Great Point Partners LLC | 350,000 | $6.32M |
| EcoR1 Capital, LLC | 66,978 | $1.21M |
| Blackstone Group Inc. | 50,000 | $903.5K |
| Bellevue Group AG | 45,000 | $813.1K |
| Ergoteles LLC | 35,922 | $649.1K |
| Connor, Clark & Lunn Investment Management Ltd. | 21,824 | $394.4K |
| Caption Management, LLC | 11,944 | $215.8K |
| Impact Partnership Wealth, LLC | 57 | $1.03K |
| Signaturefd, LLC | 22 | $398 |
| Cubist Systematic Strategies, LLC | 1 | $18 |